Work in progress: 252Cf neutron brachytherapy for hemispheric malignant glioma.
- 1 October 1982
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 145 (1) , 171-174
- https://doi.org/10.1148/radiology.145.1.6289375
Abstract
252Cf neutron brachytherapy of human hemispheric malignant glioma can be readily carried out and may be combined with external, whole brain photon beam therapy of 6000 rad (60 Gy [Grays]) administered over a 5 wk-7wk period. The 10 patients who were studied tolerated both procedures well. There was improvement in performance status, and a decrease in tumor size was observed upon computed tomographic scanning.This publication has 9 references indexed in Scilit:
- SURVIVAL RESPONSE OF MALIGNANT GLIOMAS TO RADIOTHERAPY WITH OR WITHOUT BCNU OR METHYL-CCNU CHEMOTHERAPY AT THE UNIVERSITY-OF-KENTUCKY MEDICAL-CENTER1981
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- A clinical trial for advanced cervico-vaginal pelvic carcinomas using californium CF-252 fast neutron therapy: Report of early responsesInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Interstitial brachytherapy of primary brain tumorsJournal of Neurosurgery, 1980
- Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma: A controlled pilot studyInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Rapid Clearance of Advanced Pelvic Carcinomas by Low Dose Rate252Cf Neutron TherapyRadiology, 1979
- Californium Cf-252 for Pelvic RadiotherapyOncology, 1977
- Radiation and High-Dose Metronidazole in Supratentorial GlioblastomasNew England Journal of Medicine, 1976
- The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in RadiotherapyThe British Journal of Radiology, 1953